Introduction In 2021 the NHS Business Services Authority Data Science team openly published the first comprehensive nationwide analysis of over 65 care home versus non-care home prescribing (https://nhsbsa-data-analytics.shinyapps.io/estimated-prescribing-patterns-for-care-home-patients/). The analysis has been expanded to include three years of prescribing data and key falls risk prescribing metrics, offering new insight into falls risk prescribing for the over 65s in England. Method Patient address information from 800m prescription forms was matched against 35m Ordnance Survey Address Base addresses. Patient addresses from prescription forms were classified as belonging to a care home or otherwise. Prescribing metrics around volume, cost, polypharmacy and falls risk were generated, with falls risk metrics informed by the STOPPFall study drug groups (https://www.prescqipp.info/umbraco/surface/authorisedmediasurface/index?url=%2fmedia%2f6019%2f300-medication-and-falls-20.pdf). These metrics were the mean number of falls risk medicines and proportion of patients prescribed three or more falls risk medicines within a given month. Results Over 65 care home patients received more prescribing of falls risk drugs than non-care home patients, whilst the proportion of care home patients on three or more falls risk drugs within a given month was double that of non-care home patients. Nearly 40% of care home patients aged 65-69 were prescribed three of more falls risk drugs within a given month, far more than both older care home patients and non-care home patients. Falls risk prescribing metrics displayed a great deal of variation by ICS and Local Authority. Conclusion Aside from headline figures and key findings, the analysis (due for public release in September 2023) allows granular analysis of over 65 falls risk prescribing, by patient age band, gender, geography and care home setting. The exploratory nature of the analysis lends itself to further investigation by healthcare analysts and clinicians, with the aim to gather feedback, iterate and expand the content annually.

中文翻译：

---

1895 对超过 65 名护理院和非护理院患者的跌倒风险进行了三年全国分析

简介 2021 年，NHS 商业服务管理局数据科学团队公开发布了第一份针对超过 65 个护理院与非护理院处方的全国性综合分析 (https://nhsbsa-data-analytics.shinyapps.io/estimated-prescribing-patterns-为护理之家患者/）。该分析已扩展到包括三年的处方数据和关键跌倒风险处方指标，为英格兰 65 岁以上老年人的跌倒风险处方提供了新的见解。方法 将 800m 处方表中的患者地址信息与 35m 地形测量地址基本地址进行匹配。处方表中的患者地址被分类为属于疗养院或其他地址。生成了有关剂量、成本、复方用药和跌倒风险的处方指标，其中跌倒风险指标由 STOPPFall 研究药物组提供 (https://www.prescqipp.info/umbraco/surface/authorizedmediasurface/index?url=%2fmedia%2f6019 %2f300-medication-and-falls-20.pdf)。这些指标是跌倒风险药物的平均数量以及在给定月份内服用三种或更多跌倒风险药物的患者比例。结果 超过 65 名护理院患者比非护理院患者接受更多跌倒风险药物处方，而护理院患者在一个月内服用三种或更多跌倒风险药物的比例是非护理院患者的两倍。近 40% 65-69 岁的疗养院患者在一个月内服用了三种以上的跌倒风险药物，远远高于老年疗养院患者和非疗养院患者。ICS 和地方当局的跌倒风险处方指标显示出很大的差异。结论 除了标题数据和主要发现之外，该分析（将于 2023 年 9 月公开发布）还可以根据患者年龄范围、性别、地理位置和护理院环境对超过 65 种跌倒风险处方进行精细分析。该分析的探索性性质有助于医疗保健分析师和临床医生进行进一步调查，目的是每年收集反馈、迭代和扩展内容。